245 related articles for article (PubMed ID: 28654364)
1. Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
Leonard JP; Martin P; Roboz GJ
J Clin Oncol; 2017 Aug; 35(23):2708-2715. PubMed ID: 28654364
[TBL] [Abstract][Full Text] [Related]
2. The World Health Organization (WHO) classification of the myeloid neoplasms.
Vardiman JW; Harris NL; Brunning RD
Blood; 2002 Oct; 100(7):2292-302. PubMed ID: 12239137
[TBL] [Abstract][Full Text] [Related]
3. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
Vardiman JW
Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
Lynch RC; Gratzinger D; Advani RH
Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
[TBL] [Abstract][Full Text] [Related]
5. [Some suggestion of using the world health organization classification of the acute myeloid leukemia in China].
Da WM
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2105-7. PubMed ID: 15029885
[No Abstract] [Full Text] [Related]
6. The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
Arber DA
Semin Hematol; 2019 Apr; 56(2):90-95. PubMed ID: 30926096
[TBL] [Abstract][Full Text] [Related]
7. Critical evaluation of the World Health Organization classification of myelodysplasia and acute myeloid leukemia.
Heaney ML; Golde DW;
Curr Oncol Rep; 2000 Mar; 2(2):140-3. PubMed ID: 11122835
[TBL] [Abstract][Full Text] [Related]
8. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
Cucuianu A
Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
[TBL] [Abstract][Full Text] [Related]
9. [2016 revision of the WHO classification of lymphoid neoplasms].
Tamaru JI
Rinsho Ketsueki; 2017; 58(10):2188-2193. PubMed ID: 28978864
[TBL] [Abstract][Full Text] [Related]
10. [Usefulness and issue of the WHO classification of AMLs].
Kuriyama K
Rinsho Ketsueki; 2004 Jan; 45(1):6-14. PubMed ID: 14999929
[No Abstract] [Full Text] [Related]
11. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
[TBL] [Abstract][Full Text] [Related]
12. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
Tohda S
Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
[TBL] [Abstract][Full Text] [Related]
13. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
[TBL] [Abstract][Full Text] [Related]
14. The saga of JAK2 mutations and translocations in hematologic disorders: pathogenesis, diagnostic and therapeutic prospects, and revised World Health Organization diagnostic criteria for myeloproliferative neoplasms.
Smith CA; Fan G
Hum Pathol; 2008 Jun; 39(6):795-810. PubMed ID: 18538168
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukaemia: How to combine multiple tools.
Merino A; Boldú L; Ermens A
Int J Lab Hematol; 2018 May; 40 Suppl 1():109-119. PubMed ID: 29741260
[TBL] [Abstract][Full Text] [Related]
16. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Histopathology; 2000 Jan; 36(1):69-86. PubMed ID: 10632755
[TBL] [Abstract][Full Text] [Related]
17. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
Ann Oncol; 1999 Dec; 10(12):1419-32. PubMed ID: 10643532
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.
Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J
Ann Oncol; 2000; 11 Suppl 1():3-10. PubMed ID: 10707771
[TBL] [Abstract][Full Text] [Related]
19. [Guideline for AML].
Miyawaki S
Rinsho Ketsueki; 2013 Oct; 54(10):1633-42. PubMed ID: 24064812
[No Abstract] [Full Text] [Related]
20. Myeloid Neoplasm With Germline Predisposition: A 2016 Update for Pathologists.
Gao J; Gong S; Chen YH
Arch Pathol Lab Med; 2019 Jan; 143(1):13-22. PubMed ID: 29372845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
